FilingIndex
6-KThe Wire

Evogene Ltd. files 6-K

Filed Feb 25, 2026 · 4mo ago · Accession 0001178913-26-000628

Plain English

Evogene Ltd. issued a letter from its President and Chief Executive Officer to its shareholders on February 25, 2026, which was furnished as an exhibit to this report.

Read the original on SEC.gov ↗
Filing details
Ticker
EVGN
CIK
1574565
Form type
6-K
Filing date
Feb 25, 2026
Report date
Feb 25, 2026
Document
zk2634439.htm
Size
173 KB